nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefamandole—SLC22A11—Conjugated Estrogens—prostate cancer	0.223	0.258	CbGbCtD
Cefamandole—SLC22A11—Estradiol—prostate cancer	0.195	0.227	CbGbCtD
Cefamandole—SLC22A8—Conjugated Estrogens—prostate cancer	0.129	0.15	CbGbCtD
Cefamandole—SLC22A8—Estradiol—prostate cancer	0.114	0.132	CbGbCtD
Cefamandole—SLC22A7—Docetaxel—prostate cancer	0.111	0.129	CbGbCtD
Cefamandole—SLC22A6—Conjugated Estrogens—prostate cancer	0.0902	0.105	CbGbCtD
Cefamandole—PTPN7—prostate gland—prostate cancer	0.0128	0.227	CbGeAlD
Cefamandole—SLC22A8—urine—prostate cancer	0.00994	0.177	CbGeAlD
Cefamandole—PTPN7—bone marrow—prostate cancer	0.0066	0.117	CbGeAlD
Cefamandole—PTPN7—testis—prostate cancer	0.00564	0.1	CbGeAlD
Cefamandole—SLC22A11—renal system—prostate cancer	0.00431	0.0766	CbGeAlD
Cefamandole—SLC22A7—renal system—prostate cancer	0.00421	0.0747	CbGeAlD
Cefamandole—PTPN7—lymph node—prostate cancer	0.00409	0.0726	CbGeAlD
Cefamandole—SLC22A8—prostate gland—prostate cancer	0.00357	0.0634	CbGeAlD
Cefamandole—PTPN7—Ras signaling in the CD4+ TCR pathway—MAP2K1—prostate cancer	0.00343	0.0435	CbGpPWpGaD
Cefamandole—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00339	0.0429	CbGpPWpGaD
Cefamandole—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00307	0.039	CbGpPWpGaD
Cefamandole—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00276	0.035	CbGpPWpGaD
Cefamandole—SLC22A7—testis—prostate cancer	0.00272	0.0483	CbGeAlD
Cefamandole—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00258	0.0327	CbGpPWpGaD
Cefamandole—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00251	0.0318	CbGpPWpGaD
Cefamandole—SLC22A8—renal system—prostate cancer	0.00243	0.0432	CbGeAlD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—B2M—prostate cancer	0.00232	0.0294	CbGpPWpGaD
Cefamandole—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00216	0.0273	CbGpPWpGaD
Cefamandole—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00211	0.0267	CbGpPWpGaD
Cefamandole—PTPN7—Ras signaling in the CD4+ TCR pathway—KRAS—prostate cancer	0.00197	0.025	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—EGR1—prostate cancer	0.00183	0.0232	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—PRKCQ—prostate cancer	0.00182	0.0231	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—STMN1—prostate cancer	0.0018	0.0228	CbGpPWpGaD
Cefamandole—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00176	0.0223	CbGpPWpGaD
Cefamandole—SLC22A7—Fluoropyrimidine Activity—UMPS—prostate cancer	0.00165	0.0208	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—CASP6—prostate cancer	0.00152	0.0193	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—FASLG—prostate cancer	0.00141	0.0178	CbGpPWpGaD
Cefamandole—Cefazolin—PON1—prostate cancer	0.0013	0.606	CrCbGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—TGFBR1—prostate cancer	0.0011	0.0139	CbGpPWpGaD
Cefamandole—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.00105	0.0133	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—PPP3CA—prostate cancer	0.00105	0.0133	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—PRKCZ—prostate cancer	0.00101	0.0128	CbGpPWpGaD
Cefamandole—SLC22A7—Fluoropyrimidine Activity—CYP2A6—prostate cancer	0.000997	0.0126	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—MAP2K1—prostate cancer	0.000993	0.0126	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—GADD45A—prostate cancer	0.000983	0.0125	CbGpPWpGaD
Cefamandole—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.000956	0.0121	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—HSPA1A—prostate cancer	0.000927	0.0117	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—CASP9—prostate cancer	0.00089	0.0113	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—MAP3K7—prostate cancer	0.000852	0.0108	CbGpPWpGaD
Cefamandole—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.000803	0.0102	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—IL2—prostate cancer	0.00079	0.01	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—TGFBR2—prostate cancer	0.000779	0.00987	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—PDGFRB—prostate cancer	0.000696	0.00882	CbGpPWpGaD
Cefamandole—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000679	0.0086	CbGpPWpGaD
Cefamandole—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.00067	0.00849	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—FASLG—prostate cancer	0.000666	0.00843	CbGpPWpGaD
Cefamandole—SLC22A7—Fluoropyrimidine Activity—TYMS—prostate cancer	0.00065	0.00823	CbGpPWpGaD
Cefamandole—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000616	0.0078	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000605	0.00767	CbGpPWpGaD
Cefamandole—SLC22A7—Fluoropyrimidine Activity—ERCC2—prostate cancer	0.000604	0.00765	CbGpPWpGaD
Cefamandole—PTPN7—Downstream signaling in naïve CD8+ T cells—KRAS—prostate cancer	0.000571	0.00723	CbGpPWpGaD
Cefamandole—SLC22A7—Fluoropyrimidine Activity—MTHFR—prostate cancer	0.000568	0.00719	CbGpPWpGaD
Cefamandole—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000553	0.00701	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000549	0.00696	CbGpPWpGaD
Cefamandole—Cefaclor—MPO—prostate cancer	0.000527	0.246	CrCbGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—EGF—prostate cancer	0.000526	0.00666	CbGpPWpGaD
Cefamandole—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000518	0.00656	CbGpPWpGaD
Cefamandole—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000502	0.00636	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000479	0.00606	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—MAP2K1—prostate cancer	0.00047	0.00596	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000462	0.00585	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000434	0.0055	CbGpPWpGaD
Cefamandole—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000432	0.00547	CbGpPWpGaD
Cefamandole—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000422	0.00535	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000385	0.00488	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00038	0.00482	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00038	0.00482	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—CASP3—prostate cancer	0.000375	0.00475	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000365	0.00462	CbGpPWpGaD
Cefamandole—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000352	0.00446	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000345	0.00437	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000345	0.00437	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000308	0.00391	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000308	0.0039	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000305	0.00386	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—MYC—prostate cancer	0.000293	0.00371	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—TGFB1—prostate cancer	0.000292	0.0037	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00029	0.00367	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00029	0.00367	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—EGFR—prostate cancer	0.000286	0.00363	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.00028	0.00355	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000279	0.00354	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—KRAS—prostate cancer	0.00027	0.00342	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000251	0.00319	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000243	0.00308	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000242	0.00307	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000242	0.00307	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—TP53—prostate cancer	0.00024	0.00304	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000235	0.00298	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000235	0.00297	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000228	0.00289	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000221	0.0028	CbGpPWpGaD
Cefamandole—SLC22A7—Fluoropyrimidine Activity—TP53—prostate cancer	0.000216	0.00273	CbGpPWpGaD
Cefamandole—PTPN7—MAPK Signaling Pathway—AKT1—prostate cancer	0.000203	0.00257	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000198	0.00251	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000196	0.00249	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000196	0.00248	CbGpPWpGaD
Cefamandole—Cefradine—CYP3A4—prostate cancer	0.000194	0.0901	CrCbGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000193	0.00245	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000193	0.00245	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000192	0.00243	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000185	0.00235	CbGpPWpGaD
Cefamandole—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000183	0.00232	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00018	0.00228	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000175	0.00222	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000175	0.00222	CbGpPWpGaD
Cefamandole—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000166	0.00211	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.00016	0.00203	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000157	0.00199	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000155	0.00196	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000151	0.00192	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000147	0.00187	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000147	0.00187	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000145	0.00183	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000142	0.0018	CbGpPWpGaD
Cefamandole—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.00014	0.00177	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000131	0.00166	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000128	0.00162	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000126	0.0016	CbGpPWpGaD
Cefamandole—Cephalexin—CYP3A4—prostate cancer	0.000125	0.0583	CrCbGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000123	0.00156	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000123	0.00156	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000122	0.00154	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00012	0.00151	CbGpPWpGaD
Cefamandole—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000117	0.00148	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000116	0.00147	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00011	0.0014	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00011	0.0014	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000104	0.00131	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	9.98e-05	0.00126	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.77e-05	0.00124	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	9.74e-05	0.00123	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—PRKACB—prostate cancer	9.4e-05	0.00119	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.32e-05	0.00118	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—GNG5—prostate cancer	9.27e-05	0.00117	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	9.21e-05	0.00117	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—NCOA2—prostate cancer	8.86e-05	0.00112	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—SLC5A5—prostate cancer	8.46e-05	0.00107	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.23e-05	0.00104	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	8.13e-05	0.00103	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.9e-05	0.001	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—RXRA—prostate cancer	7.83e-05	0.000992	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	7.73e-05	0.00098	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—NCOA1—prostate cancer	7.47e-05	0.000946	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	7.45e-05	0.000944	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	7.11e-05	0.000901	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—RXRA—prostate cancer	7.11e-05	0.0009	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.59e-05	0.000835	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.28e-05	0.000796	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	6.22e-05	0.000788	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—PPARA—prostate cancer	5.98e-05	0.000758	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	5.97e-05	0.000757	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.93e-05	0.000752	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—PPARA—prostate cancer	5.43e-05	0.000688	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.24e-05	0.000664	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	4.98e-05	0.000632	CbGpPWpGaD
Cefamandole—SLC22A11—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.75e-05	0.000602	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	4.56e-05	0.000578	CbGpPWpGaD
Cefamandole—SLC22A7—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.31e-05	0.000546	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	3.81e-05	0.000482	CbGpPWpGaD
Cefamandole—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.62e-05	0.000459	CbGpPWpGaD
Cefamandole—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.02e-05	0.000383	CbGpPWpGaD
